nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloprost—PTGIR—endothelium—skin cancer	0.0313	0.0741	CbGeAlD
Iloprost—PTGIR—blood vessel—skin cancer	0.0289	0.0683	CbGeAlD
Iloprost—PLAT—nipple—skin cancer	0.0265	0.0627	CbGeAlD
Iloprost—SLCO3A1—nipple—skin cancer	0.0184	0.0436	CbGeAlD
Iloprost—SLCO2A1—nipple—skin cancer	0.0182	0.0432	CbGeAlD
Iloprost—SLCO2A1—neck—skin cancer	0.018	0.0427	CbGeAlD
Iloprost—PTGER1—female reproductive system—skin cancer	0.0169	0.04	CbGeAlD
Iloprost—PLAT—mammalian vulva—skin cancer	0.0155	0.0366	CbGeAlD
Iloprost—PTGIR—connective tissue—skin cancer	0.0148	0.035	CbGeAlD
Iloprost—Tafluprost—PTGS2—skin cancer	0.0146	1	CrCbGaD
Iloprost—PTGER1—head—skin cancer	0.0141	0.0334	CbGeAlD
Iloprost—PTGIR—epithelium—skin cancer	0.014	0.0333	CbGeAlD
Iloprost—PDE4B—nipple—skin cancer	0.0128	0.0303	CbGeAlD
Iloprost—SLCO2A1—epithelium—skin cancer	0.0123	0.0291	CbGeAlD
Iloprost—SLCO2A1—skin of body—skin cancer	0.0117	0.0276	CbGeAlD
Iloprost—PDE4C—head—skin cancer	0.0115	0.0272	CbGeAlD
Iloprost—SLCO3A1—mammalian vulva—skin cancer	0.0108	0.0255	CbGeAlD
Iloprost—SLCO2A1—mammalian vulva—skin cancer	0.0107	0.0252	CbGeAlD
Iloprost—PTGIR—female reproductive system—skin cancer	0.0104	0.0247	CbGeAlD
Iloprost—SLCO3A1—female reproductive system—skin cancer	0.00921	0.0218	CbGeAlD
Iloprost—SLCO2A1—female reproductive system—skin cancer	0.00912	0.0216	CbGeAlD
Iloprost—PTGIR—head—skin cancer	0.00872	0.0206	CbGeAlD
Iloprost—PLAT—lymph node—skin cancer	0.00775	0.0184	CbGeAlD
Iloprost—SLCO3A1—head—skin cancer	0.0077	0.0182	CbGeAlD
Iloprost—SLCO2A1—head—skin cancer	0.00762	0.018	CbGeAlD
Iloprost—PDE4B—mammalian vulva—skin cancer	0.00747	0.0177	CbGeAlD
Iloprost—PDE4D—lymph node—skin cancer	0.00709	0.0168	CbGeAlD
Iloprost—PDE4B—lymphoid tissue—skin cancer	0.00663	0.0157	CbGeAlD
Iloprost—SLCO2B1—female reproductive system—skin cancer	0.00653	0.0155	CbGeAlD
Iloprost—PDE4B—female reproductive system—skin cancer	0.0064	0.0151	CbGeAlD
Iloprost—PDE4A—lymph node—skin cancer	0.00628	0.0149	CbGeAlD
Iloprost—PTGIR—lymph node—skin cancer	0.00611	0.0145	CbGeAlD
Iloprost—SLCO2B1—head—skin cancer	0.00546	0.0129	CbGeAlD
Iloprost—SLCO3A1—lymph node—skin cancer	0.00539	0.0128	CbGeAlD
Iloprost—PDE4B—head—skin cancer	0.00534	0.0126	CbGeAlD
Iloprost—SLCO2A1—lymph node—skin cancer	0.00534	0.0126	CbGeAlD
Iloprost—SLCO2B1—lymph node—skin cancer	0.00382	0.00904	CbGeAlD
Iloprost—PDE4B—lymph node—skin cancer	0.00374	0.00886	CbGeAlD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00219	0.00389	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00219	0.00389	CbGpPWpGaD
Iloprost—SLCO2B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00218	0.00387	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—RHOU—skin cancer	0.00218	0.00387	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—RHOU—skin cancer	0.00218	0.00387	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—RHOU—skin cancer	0.00215	0.00382	CbGpPWpGaD
Iloprost—PLAT—Folate Metabolism—IL6—skin cancer	0.00206	0.00367	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—RHOU—skin cancer	0.00205	0.00364	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—PTCH2—skin cancer	0.00204	0.00363	CbGpPWpGaD
Iloprost—PDE4C—G Protein Signaling Pathways—NRAS—skin cancer	0.00193	0.00342	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—RHOU—skin cancer	0.00189	0.00337	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—SHH—skin cancer	0.00181	0.00321	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—SHH—skin cancer	0.00181	0.00321	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—PTCH2—skin cancer	0.0018	0.0032	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—PTCH2—skin cancer	0.0018	0.0032	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—PTCH2—skin cancer	0.00178	0.00316	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—SMO—skin cancer	0.00171	0.00304	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—PTCH1—skin cancer	0.00171	0.00304	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—SMO—skin cancer	0.00171	0.00304	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—PTCH1—skin cancer	0.00171	0.00304	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—PTCH2—skin cancer	0.00169	0.00301	CbGpPWpGaD
Iloprost—PDE4D—G Protein Signaling Pathways—NRAS—skin cancer	0.00168	0.00298	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—PTGER4—skin cancer	0.00167	0.00296	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—PTGER4—skin cancer	0.00167	0.00296	CbGpPWpGaD
Iloprost—PDE4C—G Protein Signaling Pathways—KRAS—skin cancer	0.00166	0.00295	CbGpPWpGaD
Iloprost—PLAT—Selenium Micronutrient Network—IL6—skin cancer	0.00164	0.00291	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—MC1R—skin cancer	0.00163	0.00289	CbGpPWpGaD
Iloprost—PDE4D—TSH signaling pathway—HRAS—skin cancer	0.00161	0.00287	CbGpPWpGaD
Iloprost—PDE4A—G Protein Signaling Pathways—NRAS—skin cancer	0.0016	0.00284	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—PTCH2—skin cancer	0.00157	0.00278	CbGpPWpGaD
Iloprost—PLAT—Senescence and Autophagy in Cancer—TP53—skin cancer	0.00156	0.00276	CbGpPWpGaD
Iloprost—PLAT—Senescence and Autophagy in Cancer—HRAS—skin cancer	0.00149	0.00264	CbGpPWpGaD
Iloprost—PDE4B—G Protein Signaling Pathways—NRAS—skin cancer	0.00148	0.00262	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—MC1R—skin cancer	0.00148	0.00262	CbGpPWpGaD
Iloprost—PDE4D—G Protein Signaling Pathways—KRAS—skin cancer	0.00144	0.00256	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—MC1R—skin cancer	0.00143	0.00255	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—MC1R—skin cancer	0.00143	0.00255	CbGpPWpGaD
Iloprost—PLAT—Senescence and Autophagy in Cancer—IL6—skin cancer	0.00142	0.00253	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—MC1R—skin cancer	0.00142	0.00252	CbGpPWpGaD
Iloprost—PDE4C—G Protein Signaling Pathways—HRAS—skin cancer	0.00141	0.0025	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—PTCH2—skin cancer	0.0014	0.00249	CbGpPWpGaD
Iloprost—PDE4A—G Protein Signaling Pathways—KRAS—skin cancer	0.00137	0.00244	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—MC1R—skin cancer	0.00135	0.00239	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—NRAS—skin cancer	0.00131	0.00233	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—MC1R—skin cancer	0.0013	0.00231	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—MC1R—skin cancer	0.0013	0.00231	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—MC1R—skin cancer	0.00129	0.00228	CbGpPWpGaD
Iloprost—PDE4B—G Protein Signaling Pathways—KRAS—skin cancer	0.00127	0.00226	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—MC1R—skin cancer	0.00125	0.00222	CbGpPWpGaD
Iloprost—PDE4D—G Protein Signaling Pathways—HRAS—skin cancer	0.00123	0.00218	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—MC1R—skin cancer	0.00122	0.00217	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PTCH2—skin cancer	0.00121	0.00214	CbGpPWpGaD
Iloprost—PDE4A—G Protein Signaling Pathways—HRAS—skin cancer	0.00117	0.00207	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—MC1R—skin cancer	0.00113	0.00201	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—KRAS—skin cancer	0.00113	0.002	CbGpPWpGaD
Iloprost—PDE4B—G Protein Signaling Pathways—HRAS—skin cancer	0.00108	0.00192	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—PTGER4—skin cancer	0.00107	0.0019	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—GLI2—skin cancer	0.00106	0.00189	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PTCH2—skin cancer	0.00106	0.00189	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PTCH2—skin cancer	0.00106	0.00189	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—SHH—skin cancer	0.00105	0.00187	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PTCH2—skin cancer	0.00105	0.00187	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—MC1R—skin cancer	0.00101	0.0018	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PTCH2—skin cancer	0.001	0.00178	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—GLI1—skin cancer	0.001	0.00178	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—SMO—skin cancer	0.000998	0.00177	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—PTCH1—skin cancer	0.000998	0.00177	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—PTGER4—skin cancer	0.000971	0.00173	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—HRAS—skin cancer	0.000958	0.0017	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—SUFU—skin cancer	0.000948	0.00168	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—PTGER4—skin cancer	0.000943	0.00167	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—PTGER4—skin cancer	0.000943	0.00167	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—PTGER4—skin cancer	0.000931	0.00165	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—SHH—skin cancer	0.000928	0.00165	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—SHH—skin cancer	0.000928	0.00165	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PTCH2—skin cancer	0.000925	0.00164	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—IL6—skin cancer	0.000917	0.00163	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—SHH—skin cancer	0.000916	0.00163	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—GLI2—skin cancer	0.000915	0.00162	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—PTGER4—skin cancer	0.000886	0.00157	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—PTCH1—skin cancer	0.000879	0.00156	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—PTCH1—skin cancer	0.000879	0.00156	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—SMO—skin cancer	0.000879	0.00156	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—SMO—skin cancer	0.000879	0.00156	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—MC1R—skin cancer	0.000873	0.00155	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—SHH—skin cancer	0.000872	0.00155	CbGpPWpGaD
Iloprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000869	0.00154	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—SMO—skin cancer	0.000869	0.00154	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—PTCH1—skin cancer	0.000869	0.00154	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—GLI1—skin cancer	0.00086	0.00153	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—PTGER4—skin cancer	0.000856	0.00152	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—PTGER4—skin cancer	0.000856	0.00152	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—PTGER4—skin cancer	0.000846	0.0015	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—SMO—skin cancer	0.000827	0.00147	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—PTCH1—skin cancer	0.000827	0.00147	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—PTGER4—skin cancer	0.00082	0.00146	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—SUFU—skin cancer	0.000815	0.00145	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—SHH—skin cancer	0.000807	0.00143	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—GLI2—skin cancer	0.000806	0.00143	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—GLI2—skin cancer	0.000806	0.00143	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—PTGER4—skin cancer	0.000805	0.00143	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—GLI2—skin cancer	0.000796	0.00141	CbGpPWpGaD
Iloprost—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.00078	0.00139	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—MC1R—skin cancer	0.000769	0.00137	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—MC1R—skin cancer	0.000769	0.00137	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—PTCH1—skin cancer	0.000765	0.00136	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—SMO—skin cancer	0.000765	0.00136	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—MC1R—skin cancer	0.00076	0.00135	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—GLI2—skin cancer	0.000758	0.00135	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—GLI1—skin cancer	0.000758	0.00135	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—GLI1—skin cancer	0.000758	0.00135	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—GLI1—skin cancer	0.000749	0.00133	CbGpPWpGaD
Iloprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000748	0.00133	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—PTGER4—skin cancer	0.000745	0.00132	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—SHH—skin cancer	0.000723	0.00128	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—MC1R—skin cancer	0.000723	0.00128	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—SUFU—skin cancer	0.000718	0.00128	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—RASA1—skin cancer	0.000718	0.00128	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—SUFU—skin cancer	0.000718	0.00128	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—GLI1—skin cancer	0.000713	0.00127	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—SUFU—skin cancer	0.00071	0.00126	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—GLI2—skin cancer	0.000701	0.00125	CbGpPWpGaD
Iloprost—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000687	0.00122	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—SMO—skin cancer	0.000685	0.00122	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—PTCH1—skin cancer	0.000685	0.00122	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—SUFU—skin cancer	0.000675	0.0012	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—MC1R—skin cancer	0.000669	0.00119	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—PTGER4—skin cancer	0.000667	0.00119	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—GLI1—skin cancer	0.000659	0.00117	CbGpPWpGaD
Iloprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000635	0.00113	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—SUFU—skin cancer	0.000625	0.00111	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—SHH—skin cancer	0.000622	0.0011	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—RASA1—skin cancer	0.000618	0.0011	CbGpPWpGaD
Iloprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000608	0.00108	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—FOXO4—skin cancer	0.000589	0.00105	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PTCH1—skin cancer	0.000589	0.00105	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—SMO—skin cancer	0.000589	0.00105	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—NRAS—skin cancer	0.000578	0.00103	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—PTGER4—skin cancer	0.000574	0.00102	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—SHH—skin cancer	0.000548	0.000973	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—SHH—skin cancer	0.000548	0.000973	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—RASA1—skin cancer	0.000544	0.000967	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—RASA1—skin cancer	0.000544	0.000967	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—SHH—skin cancer	0.000541	0.000961	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—RASA1—skin cancer	0.000538	0.000955	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—SMO—skin cancer	0.000519	0.000923	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—SMO—skin cancer	0.000519	0.000923	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PTCH1—skin cancer	0.000519	0.000923	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PTCH1—skin cancer	0.000519	0.000923	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—SHH—skin cancer	0.000515	0.000915	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PTCH1—skin cancer	0.000513	0.000911	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—SMO—skin cancer	0.000513	0.000911	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—RASA1—skin cancer	0.000512	0.000909	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—FOXO4—skin cancer	0.000507	0.0009	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—PTGER4—skin cancer	0.000506	0.000898	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—PTGER4—skin cancer	0.000506	0.000898	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—PTGER4—skin cancer	0.000499	0.000887	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—KRAS—skin cancer	0.000497	0.000884	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PTCH1—skin cancer	0.000488	0.000868	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—SMO—skin cancer	0.000488	0.000868	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—SHH—skin cancer	0.000477	0.000847	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—PTGER4—skin cancer	0.000475	0.000845	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—RASA1—skin cancer	0.000474	0.000841	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PTCH1—skin cancer	0.000452	0.000803	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—SMO—skin cancer	0.000452	0.000803	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—FOXO4—skin cancer	0.000447	0.000793	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—FOXO4—skin cancer	0.000447	0.000793	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—TP53—skin cancer	0.000442	0.000785	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—FOXO4—skin cancer	0.000441	0.000784	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—PTGER4—skin cancer	0.00044	0.000781	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—NRAS—skin cancer	0.000438	0.000778	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—HRAS—skin cancer	0.000423	0.000751	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—FOXO4—skin cancer	0.00042	0.000746	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—TERT—skin cancer	0.000394	0.000699	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—FOXO4—skin cancer	0.000389	0.00069	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—KRAS—skin cancer	0.000377	0.00067	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—TERT—skin cancer	0.000339	0.000601	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—TP53—skin cancer	0.000335	0.000595	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—HRAS—skin cancer	0.00032	0.000569	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—BRAF—skin cancer	0.000312	0.000554	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—TERT—skin cancer	0.000298	0.00053	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—TERT—skin cancer	0.000298	0.00053	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—TERT—skin cancer	0.000295	0.000523	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—NRAS—skin cancer	0.000285	0.000507	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—TERT—skin cancer	0.00028	0.000498	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—BRAF—skin cancer	0.000268	0.000476	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—TERT—skin cancer	0.00026	0.000461	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—NRAS—skin cancer	0.000251	0.000447	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—NRAS—skin cancer	0.000251	0.000447	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—NRAS—skin cancer	0.000248	0.000441	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—KRAS—skin cancer	0.000245	0.000436	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—NRAS—skin cancer	0.000236	0.00042	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—BRAF—skin cancer	0.000236	0.00042	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—BRAF—skin cancer	0.000236	0.00042	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—BRAF—skin cancer	0.000233	0.000415	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—BRAF—skin cancer	0.000222	0.000395	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—NRAS—skin cancer	0.000219	0.000388	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—KRAS—skin cancer	0.000216	0.000384	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—KRAS—skin cancer	0.000216	0.000384	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—KRAS—skin cancer	0.000214	0.00038	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—HRAS—skin cancer	0.000209	0.000371	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—BRAF—skin cancer	0.000206	0.000365	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—KRAS—skin cancer	0.000203	0.000361	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—IL6—skin cancer	0.0002	0.000355	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—NRAS—skin cancer	0.000196	0.000348	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—KRAS—skin cancer	0.000188	0.000334	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—HRAS—skin cancer	0.000184	0.000327	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—HRAS—skin cancer	0.000184	0.000327	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—HRAS—skin cancer	0.000182	0.000323	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—IL6—skin cancer	0.000176	0.000313	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—IL6—skin cancer	0.000176	0.000313	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—IL6—skin cancer	0.000174	0.000309	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—HRAS—skin cancer	0.000173	0.000307	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—KRAS—skin cancer	0.000169	0.0003	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—NRAS—skin cancer	0.000168	0.000299	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—IL6—skin cancer	0.000165	0.000294	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—HRAS—skin cancer	0.00016	0.000284	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—IL6—skin cancer	0.000153	0.000272	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—TP53—skin cancer	0.00015	0.000266	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—NRAS—skin cancer	0.000148	0.000264	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—NRAS—skin cancer	0.000148	0.000264	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—NRAS—skin cancer	0.000147	0.000261	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—KRAS—skin cancer	0.000145	0.000258	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—HRAS—skin cancer	0.000143	0.000255	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—NRAS—skin cancer	0.00014	0.000248	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—IL6—skin cancer	0.000137	0.000244	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—NRAS—skin cancer	0.000129	0.000229	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—TP53—skin cancer	0.000129	0.000229	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—KRAS—skin cancer	0.000128	0.000227	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—KRAS—skin cancer	0.000128	0.000227	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—KRAS—skin cancer	0.000126	0.000224	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—HRAS—skin cancer	0.000123	0.000219	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—KRAS—skin cancer	0.00012	0.000213	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—IL6—skin cancer	0.000118	0.00021	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—TP53—skin cancer	0.000114	0.000202	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—TP53—skin cancer	0.000114	0.000202	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—TP53—skin cancer	0.000112	0.000199	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—KRAS—skin cancer	0.000111	0.000197	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—HRAS—skin cancer	0.000109	0.000193	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—HRAS—skin cancer	0.000109	0.000193	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—HRAS—skin cancer	0.000107	0.000191	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—TP53—skin cancer	0.000107	0.00019	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IL6—skin cancer	0.000104	0.000185	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IL6—skin cancer	0.000104	0.000185	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IL6—skin cancer	0.000103	0.000182	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—HRAS—skin cancer	0.000102	0.000181	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—TP53—skin cancer	9.88e-05	0.000176	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IL6—skin cancer	9.77e-05	0.000174	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—HRAS—skin cancer	9.45e-05	0.000168	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IL6—skin cancer	9.04e-05	0.000161	CbGpPWpGaD
